View the LUCICYP registration information details.
Back to drug list
ItemsDrug Registration information
ID1706
No1706
Brand NameLUCICYP
IngredientsCYPROTERONE ACETATE 50 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 5 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsINDICATION IN FEMALE: SEVERE SIGN OF ANDROGENISATION E.G.VERY SEVERE HIRSUTISM, ANDROGEN DEPENDENT SEVERE LOSS OF SCLAP HAIR EVENTUALLY RESULTING IN BALDNESS, OFTEN ATTENED BY SEVERE FORMS OF ACNE OR SEBORROEA. INDICATION IN MALE: REUCTION OF DRIVES IN SEXUAL DEVIATION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE ROUND TABLET, WITH LUS ON ONE SIDE AND A BREAKLINE ON THE OTHER SIDE
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 L 1038/23
FDD Registration Date17/11/2023
Expiry Date16/11/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA